Soliris
SOLIRIS is a prescription medicine used to treat adults with a disease called generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive.
SOLIRIS is a prescription medicine used to treat adults with a disease called generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive.
SOLIRIS is a treatment that is given by intravenous (IV) infusion. Some people visit an infusion center to receive SOLIRIS while others prefer to have a visiting nurse administer their infusion at home. The location in which you receive your infusion can depend on your insurance and where you live.
Planning ahead can help you manage your appointments as well as prepare activities that you can do while receiving your SOLIRIS treatment.
Be sure to arrive early for your appointment to fill out or sign any necessary paperwork. Once your infusion begins, it usually takes about 35 minutes to complete. Afterward, you will need to be monitored for at least 1 hour to ensure there are no infusion-related reactions.
Dosing occurs in 2 phases.
SOLIRIS can cause serious side effects including serious infusion-related reactions. Tell your doctor or nurse right away if you get any of these symptoms during your SOLIRIS infusion:
If you have an infusion-related reaction to SOLIRIS, your doctor may need to infuse SOLIRIS more slowly, or stop SOLIRIS.